Iris Zelda Ana 🐰

@iridaceae.bsky.social

she/her 🐰19 🐰 artist and animator 🐰 loves magical girls and guilty gear comms are open ! kofi - https://ko-fi.com/iridaceae

the hysteria has gone off the rails so far that the average american thinks 1 in 5 people are transgender. pure absolute insanity that is driving the current lavender scare

Bild

Genuinely happy that the 7 year long development time was spent working at a leisurely pace, spending time with their families and flexing their creative muscles - with no pressure to expand their company, deliver sooner or read a single reddit post. Smartest people in our entire industry.

Jason Schreier@jasonschreier.bsky.social · last yr.

BREAKING: Silksong will be out on September 4. Two weeks from today. Really. Often, games that take 7+ years to make are plagued by mismanagement and painful burnout. But for Silksong? Team Cherry was having a blast. They still are. This is their story: www.bloomberg.com/news/newslet...

Every reputable expert I know considers mRNA vaccine technology to be one of the most revolutionary advances in medicine in our lifetimes. Its inventors won the Nobel Prize in 2023. Shutting it down now is pointless self-harm to humanity.

Eric Michael Garcia@ericmgarcia.bsky.social · last yr.

Release from HHS: HHS will wind down its development of the mRNA vaccine development activities under the Biomedical Advanced Research and Development Authority (BARDA).

HHS Winds Down mRNA Vaccine Development Under BARDA

 

WASHINGTON, DC—AUGUST 5, 2025—The U.S. Department of Health and Human Services (HHS) today announced the beginning of a coordinated wind-down of its mRNA vaccine development activities under the Biomedical Advanced Research and Development Authority (BARDA), including the cancellation and de-scoping of various contracts and solicitations. The decision follows a comprehensive review of mRNA-related investments initiated during the COVID-19 public health emergency.

 

“We reviewed the science, listened to the experts, and acted,” said HHS Secretary Robert F. Kennedy, Jr. “BARDA is terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu. We’re shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate.”